Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Total IgG in Healthy Subjects and Advanced Solid Tumors
NCT03695757Phase 2Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Nov 2018
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of autologous immunoglobulin in solid tumor (advanced stage), sponsored by Ajou University School of Medicine. Started Nov 2018; status: completed.
02
Drugs
autologous immunoglobulin
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03695757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695757.